Inovio Pharmaceuticals, Inc. (INO) stock
INONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.23 (+16.43%)
Close on Nov 17, 2026Market cap $168.54MP/E –Yield –
Inovio Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Inovio Pharmaceuticals's price to sales ratio was 478.9× on Jan 30, 2026, against 231.6× a year earlier. Over the last 5 years it ranged from 10.0× to 478.9×, with a median of 244.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 478.9× | +5.7 |
| 2025 | Oct 31, 2025 | 473.2× | +238.9 |
| 2024 | Dec 31, 2024 | 234.4× | +73.3 |
| 2023 | Dec 29, 2023 | 161.1× | +125.6 |
| 2022 | Dec 30, 2022 | 35.5× | −125.6 |
| 2021 | Dec 31, 2021 | 161.1× | −135.5 |
| 2020 | Apr 30, 2020 | 296.6× | +245.0 |
| 2019 | Dec 31, 2019 | 51.6× | +41.3 |
| 2018 | Dec 31, 2018 | 10.3× | +1.4 |
| 2017 | Dec 29, 2017 | 8.9× | −6.8 |
| 2016 | Dec 30, 2016 | 15.7× | +2.6 |
| 2015 | Dec 31, 2015 | 13.1× | −43.9 |
| 2014 | Dec 31, 2014 | 57.0× | +10.2 |
| 2013 | Dec 31, 2013 | 46.8× | +32.3 |
| 2012 | Dec 31, 2012 | 14.5× | +5.9 |
| 2011 | Jul 29, 2011 | 8.5× | – |
See a number that looks wrong?